4.7 Review

Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia

Related references

Note: Only part of the references are listed.
Article Otorhinolaryngology

Treatment Outcome Measures for Spasmodic Dysphonia: A Systematic Review

Anna Rumbach et al.

JOURNAL OF VOICE (2022)

Article Clinical Neurology

Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia

Lena C. O'Flynn et al.

Summary: This study investigated the short-term and long-term effects of BoNT treatment on brain function in patients with LD. The results suggest that BoNT-treated patients who benefited from the treatment had reduced activity in the left precuneus compared to untreated patients and patients who did not benefit from the treatment. Additionally, BoNT-treated patients with adductor LD showed decreased activity in the right thalamus, while patients with abductor LD showed reduced activity in the left inferior frontal cortex. There were no significant differences in brain activity between patients with shorter and longer treatment durations. However, patients with intermediate treatment duration of 6-12 years showed reduced activity in the right cerebellum and right prefrontal cortex compared to patients with shorter treatment duration.

NEUROLOGY (2022)

Article Otorhinolaryngology

IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial

Nikita Kohli et al.

Summary: This study demonstrates the efficacy of incobotulinumtoxinA in the treatment of adductor spasmodic dysphonia and its potential as an alternative for non-responders to onabotulinumtoxinA.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2022)

Review Otorhinolaryngology

The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan

Masamitsu Hyodo et al.

Summary: Spasmodic dysphonia in Japan has a similar prevalence to that in the USA and Iceland, with a predominance of adductor SD, higher incidence in females, and younger age of onset. Botulinum toxin injection is the most common treatment, while type 2 thyroplasty is becoming more popular.

AURIS NASUS LARYNX (2021)

Article Otorhinolaryngology

Alternating Unilateral Versus Bilateral Injections of Botulinum Toxin for the Treatment of Adductor Spasmodic Dysphonia

Seung Jin Lee et al.

Summary: The study compared the long-term efficacy, durability, and dose and interval stability between alternating unilateral and bilateral injections of botulinum toxin A for adductor spasmodic dysphonia. Results showed that both injection methods exhibited a long-term decreasing dosing trend with comparable levels of efficacy, durability, and stability, suggesting that alternating unilateral injections can be routinely performed with fewer side effects than bilateral injections.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Review Food Science & Technology

Botulinum Toxin in Movement Disorders: An Update

Charenya Anandan et al.

Summary: BoNT has evolved into a therapeutic modality for a variety of neurological and non-neurological disorders since its initial approval in 1989. It has shown effectiveness in treating neurologic movement disorders and is being researched for potential central nervous system applications. BoNT is considered safe when administered by knowledgeable clinicians and has shown promise in recent innovative pilot studies.

TOXINS (2021)

Review Food Science & Technology

The Central Effects of Botulinum Toxin in Dystonia and Spasticity

Pavel Hok et al.

Summary: Intramuscular application of BoNT-A plays a crucial role in regulating plastic changes within the sensorimotor cortex, serving as an effective treatment for dystonic and spastic movement disorders. Studies utilizing electrophysiology and neuroimaging further enhance our understanding of the pathophysiology underlying these conditions and may lead to the development of novel treatment strategies based on neural plasticity.

TOXINS (2021)

Article Food Science & Technology

Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan

Masamitsu Hyodo et al.

Summary: Spasmodic dysphonia is a rare voice disorder predominantly affecting young women, with a recent series of clinical studies conducted in Japan leading to the development of diagnostic criteria and treatment methods.

TOXINS (2021)

Article Clinical Neurology

Thalamic Deep Brain Stimulation for Spasmodic Dysphonia: A Phase I Prospective Randomized Double-Blind Crossover Trial

Christopher R. Honey et al.

Summary: The study confirmed the safety of DBS in patients with SD through a phase I trial, showing a trend towards improved quality of life and voice with blinded DBS despite a small sample size. Secondary outcomes indicated no impact on cognition, but improvements in mood and quality of life.

NEUROSURGERY (2021)

Article Otorhinolaryngology

Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan

Kahori Hirose et al.

Summary: Botulinum toxin (BT) therapy was found to be effective for adductor spasmodic dysphonia (ADSD) based on both objective and subjective assessments in this study. The therapeutic effect included reduction in aberrant phonemes, improvement in voice parameters, and better outcomes in younger patients and those experiencing post-treatment breathy hoarseness or dysphagia.

LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2021)

Article Medicine, Research & Experimental

Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia in a large cohort

Ishaan Dharia et al.

LARYNGOSCOPE (2020)

Article Medicine, Research & Experimental

Respiratory Laryngeal Dystonia: Characterization and Diagnosis of a Rare Neurogenic Disorder

William S. Tierney et al.

LARYNGOSCOPE (2020)

Review Clinical Neurology

Defining research priorities in dystonia

Codrin Lungu et al.

NEUROLOGY (2020)

Article Otorhinolaryngology

Factors Associated with Failure of Botulinum Toxin Injection in Adductor Spasmodic Dysphonia

Kevin Zhao et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2020)

Article Neurosciences

The large-scale structural connectome of task-specific focal dystonia

Sandra Hanekamp et al.

HUMAN BRAIN MAPPING (2020)

Review Otorhinolaryngology

What Is New in Laryngeal Dystonia: Review of Novel Findings of Pathophysiology and Novel Treatment Options

Necati Enver et al.

CURRENT OTORHINOLARYNGOLOGY REPORTS (2020)

Article Audiology & Speech-Language Pathology

Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia

Karuna Dewan et al.

JOURNAL OF VOICE (2019)

Article Clinical Neurology

The extrinsic risk and its association with neural alterations in spasmodic dysphonia

Laura de Lima Xavier et al.

PARKINSONISM & RELATED DISORDERS (2019)

Review Food Science & Technology

Immunogenicity Associated with Botulinum Toxin Treatment

Steven Bellows et al.

TOXINS (2019)

Article Multidisciplinary Sciences

Laryngeal vibration as a non-invasive neuromodulation therapy for spasmodic dysphonia

Sanaz Khosravani et al.

SCIENTIFIC REPORTS (2019)

Article Medicine, Research & Experimental

Validation of the OMNI vocal effort scale in the treatment of adductor spasmodic dysphonia

Hagit Shoffel-Havakuk et al.

LARYNGOSCOPE (2019)

Article Medicine, Research & Experimental

Common practices in botulinum toxin injection for spasmodic dysphonia treatment: A national survey

Hagit Shoffel-Havakuk et al.

LARYNGOSCOPE (2019)

Review Food Science & Technology

Central Effects of Botulinum NeurotoxinEvidence from Human Studies

David Weise et al.

TOXINS (2019)

Article Medicine, Research & Experimental

Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience

Andrew Blitzer et al.

LARYNGOSCOPE (2018)

Article Pharmacology & Pharmacy

Mechanism of action of botulinum neurotoxin: Unexpected consequences

Mark Hallett

TOXICON (2018)

Article Pharmacology & Pharmacy

An update on new and unique uses of botulinum toxin in movement disorders

Joseph Jankovic

TOXICON (2018)

Article Otorhinolaryngology

Consensus-Based Attributes for Identifying Patients With Spasmodic Dysphonia and Other Voice Disorders

Christy L. Ludlow et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)

Article Multidisciplinary Sciences

A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity

Kristina Simonyan et al.

SCIENTIFIC REPORTS (2018)

Article Neuroimaging

Neural correlates of dystonic tremor: a multimodal study of voice tremor in spasmodic dysphonia

Diana N. Kirke et al.

BRAIN IMAGING AND BEHAVIOR (2017)

Article Medicine, Research & Experimental

An Open-Label Study of Sodium Oxybate in Spasmodic Dysphonia

Anna F. Rumbach et al.

LARYNGOSCOPE (2017)

Article Medicine, Research & Experimental

Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia

Michael Z. Lerner et al.

LARYNGOSCOPE (2017)

Article Clinical Neurology

Phenotype- and Genotype-Specific Structural Alterations in Spasmodic Dysphonia

Serena Bianchi et al.

MOVEMENT DISORDERS (2017)

Review Clinical Neurology

Botulinum Toxin: State of the Art

Joseph Jankovic

MOVEMENT DISORDERS (2017)

Review Otorhinolaryngology

Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors

Justin M. Hintze et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)

Review Otorhinolaryngology

Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology

Justin M. Hintze et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)

Review Food Science & Technology

Chemodenervation of the Larynx

Rachel Kaye et al.

TOXINS (2017)

Article Medicine, Research & Experimental

Onabotulinum toxin A dosage trends over time for adductor spasmodic dysphonia: A 15-year experience

Christopher G. Tang et al.

LARYNGOSCOPE (2016)

Article Medicine, Research & Experimental

Botulinum Toxin Treatment of False Vocal Folds in Adductor Spasmodic Dysphonia: Functional Outcomes

C. Blake Simpson et al.

LARYNGOSCOPE (2016)

Article Otorhinolaryngology

Tracing Spasmodic Dysphonia: The Source of Ludwig Traube's Priority

Marjorie Perlman Lorch et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2016)

Article Neuroimaging

Neural correlates of abnormal sensory discrimination in laryngeal dystonia

Pichet Termsarasab et al.

NEUROIMAGE-CLINICAL (2016)

Article Clinical Neurology

Cortical Silent Period Reveals Differences Between Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia

Sharyl Samargia et al.

NEUROREHABILITATION AND NEURAL REPAIR (2016)

Article Otorhinolaryngology

Value of Laryngeal Electromyography in Spasmodic Dysphonia Diagnosis and Therapy

Qingwen Yang et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2015)

Article Clinical Neurology

Alcohol responsiveness in laryngeal dystonia: a survey study

Diana N. Kirke et al.

JOURNAL OF NEUROLOGY (2015)

Article Audiology & Speech-Language Pathology

Task-Specific Singing Dystonia: Vocal Instability That Technique Cannot Fix

Lucinda A. Halstead et al.

JOURNAL OF VOICE (2015)

Article Audiology & Speech-Language Pathology

Impaired Limb Proprioception in Adults With Spasmodic Dysphonia

Juergen Konczak et al.

JOURNAL OF VOICE (2015)

Article Clinical Neurology

Primary somatosensory cortical plasticity and tactile temporal discrimination in focal hand dystonia

Antonella Conte et al.

CLINICAL NEUROPHYSIOLOGY (2014)

Article Audiology & Speech-Language Pathology

Pyridostigmine for Reversal of Severe Sequelae From Botulinum Toxin Injection

David L. Young et al.

JOURNAL OF VOICE (2014)

Article Audiology & Speech-Language Pathology

Influence of Consonant Voicing Characteristics on Sentence Production in Abductor Versus Adductor Spasmodic Dysphonia

Michael P. Cannito et al.

JOURNAL OF VOICE (2014)

Article Otorhinolaryngology

The Role of Laryngoscopy in the Diagnosis of Spasmodic Dysphonia

Pedram Daraei et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)

Review Clinical Neurology

Immunogenicity of botulinum toxins

Markus Naumann et al.

JOURNAL OF NEURAL TRANSMISSION (2013)

Article Neurosciences

Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A

Veronique Marchand-Pauvert et al.

JOURNAL OF PHYSIOLOGY-LONDON (2013)

Article Audiology & Speech-Language Pathology

A Comparison of the VHI, VHI-10, and V-RQOL for Measuring the Effect of Botox Therapy in Adductor Spasmodic Dysphonia

Sanjay Morzaria et al.

JOURNAL OF VOICE (2012)

Article Clinical Neurology

Glucose hypermetabolism in the thalamus of patients with hemifacial spasm

Megumi Shimizu et al.

MOVEMENT DISORDERS (2012)

Review Food Science & Technology

Botulinum Toxin Physiology in Focal Hand and Cranial Dystonia

Barbara Illowsky Karp

TOXINS (2012)

Article Neurosciences

Spasmodic Dysphonia: a Laryngeal Control Disorder Specific to Speech

Christy L. Ludlow

JOURNAL OF NEUROSCIENCE (2011)

Article Audiology & Speech-Language Pathology

Interarytenoid Muscle Botox Injection for Treatment of Adductor Spasmodic Dysphonia With Vocal Tremor

Katherine A. Kendall et al.

JOURNAL OF VOICE (2011)

Article Medicine, Research & Experimental

Botulinum Toxin Treatment of Adductor Spasmodic Dysphonia: Longitudinal Functional Outcomes

Daniel Novakovic et al.

LARYNGOSCOPE (2011)

Article Clinical Neurology

Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series

A. Blitzer

EUROPEAN JOURNAL OF NEUROLOGY (2010)

Article Medicine, Research & Experimental

Abductor Paralysis After Botox Injection for Adductor Spasmodic Dysphonia

Naren N. Venkatesan et al.

LARYNGOSCOPE (2010)

Article Audiology & Speech-Language Pathology

A single-centre retrospective review of unilateral and bilateral Dysport® injections in adductor spasmodic dysphonia

Behrad Elmiyeh et al.

LOGOPEDICS PHONIATRICS VOCOLOGY (2010)

Article Dermatology

Botulinum toxin

PK Nigam et al.

INDIAN JOURNAL OF DERMATOLOGY (2010)

Article Otorhinolaryngology

Treatment for spasmodic dysphonia: limitations of current approaches

Christy L. Ludlow

CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY (2009)

Article Medicine, Research & Experimental

Influence of Age and Gender on Dose and Effectiveness of Botulinum Toxin for Laryngeal Dystonia

Silvio Vasconcelos et al.

LARYNGOSCOPE (2009)

Article Medicine, Research & Experimental

Overall evaluation of effectiveness of type II thyroplasty for adductor spasmodic dysphonia

Tetsuji Sanuki et al.

LARYNGOSCOPE (2007)

Article Medicine, Research & Experimental

Management of supraglottic squeeze in adductor spasmodic dysphonia: A new technique

Nwanmegha Young et al.

LARYNGOSCOPE (2007)

Article Audiology & Speech-Language Pathology

Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia:: An H215OPET study

S. Omar Ali et al.

JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH (2006)

Article Otorhinolaryngology

Thyrohyoid approach for vocal fold augmentation

Milan R. Amin

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2006)

Article Audiology & Speech-Language Pathology

Botulinum toxin therapy for abductor spasmodic dysphonia

G Woodson et al.

JOURNAL OF VOICE (2006)

Article Otorhinolaryngology

Singer's dystonia: First report of a variant of spasmodic dysphonia

A Chitkara et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2006)

Review Clinical Neurology

Botulinum toxin: Clinical use

Daniel D. Truong et al.

PARKINSONISM & RELATED DISORDERS (2006)

Article Otorhinolaryngology

Botulinum toxin A and B: A comparative dosing study for spasmodic dysphonia

A Blitzer

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2005)

Article Otorhinolaryngology

Bipolar radiofrequency-induced thermotherapy (rfitt) for the treatment of spasmodic dysphonia. A report of three cases

M Remacle et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2005)

Article Otorhinolaryngology

Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia

BC Stong et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2005)

Article Audiology & Speech-Language Pathology

Voice handicap index results for older patients with adductor spasmodic dysphonia

JM Wingate et al.

JOURNAL OF VOICE (2005)

Review Clinical Neurology

Botulinum toxin: Mechanisms of action

D Dressler et al.

EUROPEAN NEUROLOGY (2005)

Article Otorhinolaryngology

Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia

AD Hillel et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2004)

Article Otorhinolaryngology

Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography

DA Klotz et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2004)

Article Otorhinolaryngology

Perceptual analyses of spasmodic dysphonia before and after treatment

MP Cannito et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2004)

Review Clinical Neurology

Laryngeal electromyography: An evidence-based review

RT Sataloff et al.

MUSCLE & NERVE (2003)

Article Audiology & Speech-Language Pathology

Botulinum toxin type B for treatment of spasmodic dysphonia: A case report

RT Sataloff et al.

JOURNAL OF VOICE (2002)

Article Medicine, Research & Experimental

Risk factors and demographics in patients with spasmodic dysphonia

JM Schweinfurth et al.

LARYNGOSCOPE (2002)

Article Audiology & Speech-Language Pathology

Acoustic measures of symptoms in abductor spasmodic dysphonia

JD Edgar et al.

JOURNAL OF VOICE (2001)

Article Otorhinolaryngology

Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia

S Bielamowicz et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2001)

Article Clinical Neurology

Remote F-wave changes after local botulinum toxin application

K Wohlfarth et al.

CLINICAL NEUROPHYSIOLOGY (2001)

Article Otorhinolaryngology

Effects of botulinum toxin on pathophysiology in spasmodic dysphonia

S Bielamowicz et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2000)